Crohn's Disease (Bentz et al.)
🟡 Moderate clinical evidence (controlled clinical trial)
Study at a glance
- Participants: 40 adults
- Condition: Crohn's disease
- Study type: Double-blind, cross-over dietary intervention
- Duration: Two 6-week diet phases
What was done
Participants with Crohn's disease took a food-specific IgG blood test. They then followed two different diets:
- A diet removing foods identified by the test
- A control (sham) diet removing unrelated foods
Each participant completed both diets at different times, without knowing which one they were following.
What improved
When participants followed the IgG-guided diet:
- Symptoms improved compared to the control (sham) diet, including reductions in abdominal pain and bowel-related symptoms
- Participants reported better overall wellbeing during the IgG-guided phase
In practical terms, this means participants experienced fewer and less severe digestive symptoms when avoiding foods identified by the test.
Key takeaway
Avoiding foods identified by IgG testing was associated with reduced digestive symptoms and improved wellbeing in people with Crohn's disease.
What this means
This study suggests that food-specific IgG responses may contribute to symptom activity in Crohn's disease. Identifying and removing reactive foods may help reduce symptom burden alongside standard care.
🟡 Evidence strength
Moderate clinical evidence (controlled cross-over study)
Full citation
Bentz et al. 2010 Crohn's IgG trial
Bentz S, Hausmann M, Piberger H, et al.
Clinical relevance of IgG antibodies against food antigens in Crohn's disease: a double-blind cross-over diet intervention study.
Digestion. 2010;81(4):252–264.
Weblink:
View study
Explore other studies
- The Science Behind Food Sensitivity Testing (overview)
- Summary table of all studies
- IBS personalised diet study (Singh et al. 2025)
- IBS symptom improvement study (Atkinson et al. 2004)
- IBS diet comparison study (IgG vs FODMAP)
- Migraine improvement study (Alpay et al. 2010)
- Migraine inflammation study
- Professional athletes study
- Chronic symptoms survey study (York / Hardman & Hart)
